{"count": 44, "results": [{"_id": "36187122", "pmid": 36187122, "pmcid": "PMC9524196", "title": "Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: A systematic review, meta-analysis and meta-regression of randomized controlled trials", "journal": "Front Endocrinol (Lausanne)", "authors": ["Nabrdalik K", "Skonieczna-Żydecka K", "Irlik K", "Hendel M", "Kwiendacz H", "Łoniewski I", "Januszkiewicz K", "Gumprecht J", "Lip GYH"], "date": "2022-09-14T00:00:00Z", "doi": "10.3389/fendo.2022.975912", "meta_date_publication": "2022", "meta_volume": "13", "meta_issue": "", "meta_pages": "975912", "score": 50276.426, "text_hl": "The effect size (RR) for the @<m>DISEASE_Abdominal_Pain</m> @DISEASE_MESH:D015746 @@@abdominal pain@@@ in @SPECIES_9606 @@@patients@@@ taking @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (intervention) vs. comparator (control).", "citations": {"NLM": "Nabrdalik K, Skonieczna-Żydecka K, Irlik K, Hendel M, Kwiendacz H, Łoniewski I, Januszkiewicz K, Gumprecht J, Lip GYH. Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: A systematic review, meta-analysis and meta-regression of randomized controlled trials Front Endocrinol (Lausanne). 2022;13():975912. PMID: 36187122", "BibTeX": "@article{36187122, title={Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: A systematic review, meta-analysis and meta-regression of randomized controlled trials}, author={Nabrdalik K and Skonieczna-Żydecka K and Irlik K and Hendel M and Kwiendacz H and Łoniewski I and Januszkiewicz K and Gumprecht J and Lip GYH}, journal={Front Endocrinol (Lausanne)}, volume={13}, pages={975912}}"}}, {"_id": "36384864", "pmid": 36384864, "pmcid": "PMC9679981", "title": "Unusual Case of Metformin-Associated Lactic Acidosis in Patient with Type 2 Diabetes Mellitus", "journal": "Am J Case Rep", "authors": ["Hai PD", "Thu NT", "Phuong LL", "Manh NV", "Hoa LTV"], "date": "2022-11-17T00:00:00Z", "doi": "10.12659/AJCR.937865", "meta_date_publication": "2022 Nov 17", "meta_volume": "23", "meta_issue": "", "meta_pages": "e937865", "score": 50261.41, "text_hl": "Nevertheless, the intentional increase of his dose of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ to 3000 mg per day led to @DISEASE_Gastrointestinal_Diseases @DISEASE_MESH:D005767 @@@gastrointestinal reactions@@@, including @DISEASE_Nausea @DISEASE_MESH:D009325 @@@nausea@@@, @DISEASE_Vomiting @DISEASE_MESH:D014839 @@@vomiting@@@, @<m>DISEASE_Abdominal_Pain</m> @DISEASE_MESH:D015746 @@@abdominal pain@@@, and @DISEASE_Diarrhea @DISEASE_MESH:D003967 @@@diarrhea@@@, which caused severe @DISEASE_Dehydration @DISEASE_MESH:D003681 @@@dehydration@@@, followed by the development of @DISEASE_Acute_Kidney_Injury @DISEASE_MESH:D058186 @@@acute kidney injury@@@, one of the results of @DISEASE_Acidosis_Lactic @DISEASE_MESH:D000140 @@@MALA@@@.", "citations": {"NLM": "Hai PD, Thu NT, Phuong LL, Manh NV, Hoa LTV. Unusual Case of Metformin-Associated Lactic Acidosis in Patient with Type 2 Diabetes Mellitus Am J Case Rep. 2022 Nov 17;23():e937865. PMID: 36384864", "BibTeX": "@article{36384864, title={Unusual Case of Metformin-Associated Lactic Acidosis in Patient with Type 2 Diabetes Mellitus}, author={Hai PD and Thu NT and Phuong LL and Manh NV and Hoa LTV}, journal={Am J Case Rep}, volume={23}, pages={e937865}}"}}, {"_id": "37816179", "pmid": 37816179, "title": "Compounding Metformin for Use in Functional Medicine.", "journal": "Int J Pharm Compd", "authors": ["Desai S", "Thompson T"], "date": "2023-09-01T00:00:00Z", "meta_date_publication": "2023 Sep-Oct", "meta_volume": "27", "meta_issue": "5", "meta_pages": "362-366", "score": 50259.12, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ can cause issues with the gastrointestinal tract and result in @DISEASE_Nausea @DISEASE_MESH:D009325 @@@nausea@@@, @<m>DISEASE_Abdominal_Pain</m> @DISEASE_MESH:D015746 @@@abdominal pain@@@, @DISEASE_Diarrhea @DISEASE_MESH:D003967 @@@diarrhea@@@, @DISEASE_Gas_bloat_syndrome @DISEASE_MESH:C535647 @@@bloating@@@, or @DISEASE_Vomiting @DISEASE_MESH:D014839 @@@vomiting@@@. ", "citations": {"NLM": "Desai S, Thompson T. Compounding Metformin for Use in Functional Medicine. Int J Pharm Compd. 2023 Sep-Oct;27(5):362-366. PMID: 37816179", "BibTeX": "@article{37816179, title={Compounding Metformin for Use in Functional Medicine.}, author={Desai S and Thompson T}, journal={Int J Pharm Compd}, volume={27}, number={5}, pages={362-366}}"}}, {"_id": "38380457", "pmid": 38380457, "title": "Iatrogenic Chronic Abdominal Pain in a Geriatric Patient: A Case Report.", "journal": "Prague Med Rep", "authors": ["Wattanapisit A", "Pankamnerd N", "Wattanapisit S"], "date": "2024-01-01T00:00:00Z", "doi": "10.14712/23362936.2024.9", "meta_date_publication": "2024", "meta_volume": "125", "meta_issue": "1", "meta_pages": "87-91", "score": 50259.1, "text_hl": "Iatrogenic @<m>DISEASE_Abdominal_Pain</m> @DISEASE_MESH:D015746 @@@Chronic Abdominal Pain@@@ in a Geriatric @SPECIES_9606 @@@Patient@@@: A Case Report.", "citations": {"NLM": "Wattanapisit A, Pankamnerd N, Wattanapisit S. Iatrogenic Chronic Abdominal Pain in a Geriatric Patient: A Case Report. Prague Med Rep. 2024;125(1):87-91. PMID: 38380457", "BibTeX": "@article{38380457, title={Iatrogenic Chronic Abdominal Pain in a Geriatric Patient: A Case Report.}, author={Wattanapisit A and Pankamnerd N and Wattanapisit S}, journal={Prague Med Rep}, volume={125}, number={1}, pages={87-91}}"}}, {"_id": "36034458", "pmid": 36034458, "pmcid": "PMC9402979", "title": "Comparative efficacy and safety of glucose-lowering drugs in children and adolescents with type 2 diabetes: A systematic review and network meta-analysis", "journal": "Front Endocrinol (Lausanne)", "authors": ["Wu S", "He Y", "Wu Y", "Ji Y", "Hou L", "Liu X", "Ge Y", "Yu Y", "Yu Y", "Wei Y", "Qian F", "Luo Q", "Feng Y", "Feng Y", "Wang J", "Huo M", "Li H", "Xue F", "Liu Y"], "date": "2022-08-11T00:00:00Z", "doi": "10.3389/fendo.2022.897776", "meta_date_publication": "2022", "meta_volume": "13", "meta_issue": "", "meta_pages": "897776", "score": 50257.562, "text_hl": "There were no significant differences between treatments in the incidence of adverse events, except that liraglutide+@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ had significant adverse effect such as @<m>DISEASE_Abdominal_Pain</m> @DISEASE_MESH:D015746 @@@abdominal pain@@@. ", "citations": {"NLM": "Wu S, He Y, Wu Y, Ji Y, Hou L, Liu X, Ge Y, Yu Y, Yu Y, Wei Y, Qian F, Luo Q, Feng Y, Feng Y, Wang J, Huo M, Li H, Xue F, Liu Y. Comparative efficacy and safety of glucose-lowering drugs in children and adolescents with type 2 diabetes: A systematic review and network meta-analysis Front Endocrinol (Lausanne). 2022;13():897776. PMID: 36034458", "BibTeX": "@article{36034458, title={Comparative efficacy and safety of glucose-lowering drugs in children and adolescents with type 2 diabetes: A systematic review and network meta-analysis}, author={Wu S and He Y and Wu Y and Ji Y and Hou L and Liu X and Ge Y and Yu Y and Yu Y and Wei Y and Qian F and Luo Q and Feng Y and Feng Y and Wang J and Huo M and Li H and Xue F and Liu Y}, journal={Front Endocrinol (Lausanne)}, volume={13}, pages={897776}}"}}, {"_id": "32850203", "pmid": 32850203, "pmcid": "PMC7444850", "title": "A Case Report on Metformin-Associated Lactic Acidosis and Transient Blindness", "journal": "Cureus", "authors": ["Kalantri P", "Sahu A", "Kalantri A"], "date": "2020-07-21T00:00:00Z", "doi": "10.7759/cureus.9325", "meta_date_publication": "2020 Jul 21", "meta_volume": "12", "meta_issue": "7", "meta_pages": "e9325", "score": 50252.48, "text_hl": "However, because of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@'s large volume of distribution, the significance of these data is debatable without quantifying @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ removal. ", "citations": {"NLM": "Kalantri P, Sahu A, Kalantri A. A Case Report on Metformin-Associated Lactic Acidosis and Transient Blindness Cureus. 2020 Jul 21;12(7):e9325. PMID: 32850203", "BibTeX": "@article{32850203, title={A Case Report on Metformin-Associated Lactic Acidosis and Transient Blindness}, author={Kalantri P and Sahu A and Kalantri A}, journal={Cureus}, volume={12}, number={7}, pages={e9325}}"}}, {"_id": "33116733", "pmid": 33116733, "pmcid": "PMC7586010", "title": "Metformin Treatment: A Potential Cause of Megaloblastic Anemia in Patients with Type 2 Diabetes Mellitus", "journal": "Diabetes Metab Syndr Obes", "authors": ["Albai O", "Timar B", "Paun DL", "Sima A", "Roman D", "Timar R"], "date": "2020-10-21T00:00:00Z", "doi": "10.2147/DMSO.S270393", "meta_date_publication": "2020", "meta_volume": "13", "meta_issue": "", "meta_pages": "3873-3878", "score": 50252.36, "text_hl": "Alongside lifestyle changes, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ is indicated from the very diagnosis of the disease. ", "citations": {"NLM": "Albai O, Timar B, Paun DL, Sima A, Roman D, Timar R. Metformin Treatment: A Potential Cause of Megaloblastic Anemia in Patients with Type 2 Diabetes Mellitus Diabetes Metab Syndr Obes. 2020;13():3873-3878. PMID: 33116733", "BibTeX": "@article{33116733, title={Metformin Treatment: A Potential Cause of Megaloblastic Anemia in Patients with Type 2 Diabetes Mellitus}, author={Albai O and Timar B and Paun DL and Sima A and Roman D and Timar R}, journal={Diabetes Metab Syndr Obes}, volume={13}, pages={3873-3878}}"}}, {"_id": "34079464", "pmid": 34079464, "pmcid": "PMC8165304", "title": "Long-Acting Metformin Vs. Metformin Immediate Release in Patients With Type 2 Diabetes: A Systematic Review", "journal": "Front Pharmacol", "authors": ["Tan J", "Wang Y", "Liu S", "Shi Q", "Zhou X", "Zhou Y", "Yang X", "Chen P", "Li S"], "date": "2021-05-17T00:00:00Z", "doi": "10.3389/fphar.2021.669814", "meta_date_publication": "2021", "meta_volume": "12", "meta_issue": "", "meta_pages": "669814", "score": 50252.316, "text_hl": "@DISEASE_Gastrointestinal_Diseases @DISEASE_MESH:D005767 @@@Gastrointestinal intolerance@@@ is a major concern associated with clinical use of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@; approximately 10% of adults living with @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes@@@ are unable to receive @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment because of @DISEASE_Gastrointestinal_Diseases @DISEASE_MESH:D005767 @@@gastrointestinal intolerance@@@ including @DISEASE_Diarrhea @DISEASE_MESH:D003967 @@@diarrhea@@@, @DISEASE_Vomiting @DISEASE_MESH:D014839 @@@vomiting@@@, @<m>DISEASE_Abdominal_Pain</m> @DISEASE_MESH:D015746 @@@abdominal pain@@@, and @DISEASE_Constipation @DISEASE_MESH:D003248 @@@constipation@@@. ", "citations": {"NLM": "Tan J, Wang Y, Liu S, Shi Q, Zhou X, Zhou Y, Yang X, Chen P, Li S. Long-Acting Metformin Vs. Metformin Immediate Release in Patients With Type 2 Diabetes: A Systematic Review Front Pharmacol. 2021;12():669814. PMID: 34079464", "BibTeX": "@article{34079464, title={Long-Acting Metformin Vs. Metformin Immediate Release in Patients With Type 2 Diabetes: A Systematic Review}, author={Tan J and Wang Y and Liu S and Shi Q and Zhou X and Zhou Y and Yang X and Chen P and Li S}, journal={Front Pharmacol}, volume={12}, pages={669814}}"}}, {"_id": "35646179", "pmid": 35646179, "pmcid": "PMC9126465", "title": "Barriers against the use of an optimal dose of metformin among patients with T2DM in Thi-Qar province, Iraq", "journal": "J Med Life", "authors": ["Al-Waeli D", "Mohammed A", "Tahir I", "Al-Saeedi A", "Razzaq K", "Abodhurais A"], "date": "2022-04-01T00:00:00Z", "doi": "10.25122/jml-2021-0259", "meta_date_publication": "2022 Apr", "meta_volume": "15", "meta_issue": "4", "meta_pages": "557-562", "score": 50251.34, "text_hl": "...State of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ intake.", "citations": {"NLM": "Al-Waeli D, Mohammed A, Tahir I, Al-Saeedi A, Razzaq K, Abodhurais A. Barriers against the use of an optimal dose of metformin among patients with T2DM in Thi-Qar province, Iraq J Med Life. 2022 Apr;15(4):557-562. PMID: 35646179", "BibTeX": "@article{35646179, title={Barriers against the use of an optimal dose of metformin among patients with T2DM in Thi-Qar province, Iraq}, author={Al-Waeli D and Mohammed A and Tahir I and Al-Saeedi A and Razzaq K and Abodhurais A}, journal={J Med Life}, volume={15}, number={4}, pages={557-562}}"}}, {"_id": "32878828", "pmid": 32878828, "title": "Metformin-associated lactic acidosis: reinforcing learning points.", "journal": "BMJ Case Rep", "authors": ["Goonoo MS", "Morris R", "Raithatha A", "Creagh F"], "date": "2020-09-02T00:00:00Z", "doi": "10.1136/bcr-2020-235608", "meta_date_publication": "2020 Sep 2", "meta_volume": "13", "meta_issue": "9", "meta_pages": "", "score": 50251.26, "text_hl": "We present the case of a man in his early 20s with @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes@@@, @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ and @DISEASE_Hypothyroidism @DISEASE_MESH:D007037 @@@hypothyroidism@@@ who presented with @DISEASE_Psychomotor_Agitation @DISEASE_MESH:D011595 @@@agitation@@@, @<m>DISEASE_Abdominal_Pain</m> @DISEASE_MESH:D015746 @@@abdominal pain@@@ and @DISEASE_Vomiting @DISEASE_MESH:D014839 @@@vomiting@@@ after ingesting 50-60 g of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@; he developed severe @DISEASE_Acidosis_Lactic @DISEASE_MESH:D000140 @@@lactic acidosis@@@ (blood pH 6.93, @CHEMICAL_Bicarbonates @CHEMICAL_MESH:D001639 @@@bicarbonate@@@ 7.8 mEq/L, @CHEMICAL_Lactic_Acid @CHEMICAL_MESH:D019344 @@@lactate@@@ 28.0 mEq/L). ", "citations": {"NLM": "Goonoo MS, Morris R, Raithatha A, Creagh F. Metformin-associated lactic acidosis: reinforcing learning points. BMJ Case Rep. 2020 Sep 2;13(9):. PMID: 32878828", "BibTeX": "@article{32878828, title={Metformin-associated lactic acidosis: reinforcing learning points.}, author={Goonoo MS and Morris R and Raithatha A and Creagh F}, journal={BMJ Case Rep}, volume={13}, number={9}}"}}]}